Welcome to our dedicated page for Paychex SEC filings (Ticker: PAYX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Paychex’s SEC disclosures are more than routine paperwork—they map the health of America’s small-business economy. Inside each annual report, investors track client-count trends, interest earned on payroll tax float, and segment margins for HR outsourcing. Form 4 insider trading entries often precede shifts in service demand, while 8-K updates flag acquisitions that expand the company’s PEO footprint. If you are searching for “Paychex SEC filings explained simply” or wondering how to decode the latest “Paychex quarterly earnings report 10-Q filing,” you’re in the right place.
Stock Titan layers AI-powered summaries on top of every document so you can move from 250-page PDFs to actionable insight in minutes. Our platform highlights what matters in a “Paychex annual report 10-K simplified,” pinpoints client retention metrics in 10-Q tables, and delivers real-time alerts for “Paychex Form 4 insider transactions.” Need the fine print on executive pay? We tag the compensation tables in the proxy so “Paychex proxy statement executive compensation” is one click away. Material developments—new retirement products, wage-inflation commentary—arrive as push notifications the moment a “Paychex 8-K material events explained” hits EDGAR.
Professionals rely on these tools to:
- Monitor “Paychex insider trading Form 4 transactions” before market moves
- Compare revenue per client across quarters with AI-driven charts
- Track benefit-insurance growth using “Paychex earnings report filing analysis”
- Understand board incentives via “Paychex executive stock transactions Form 4”
- Ask natural questions like “understanding Paychex SEC documents with AI” and receive plain-English answers
No more tab-hopping or jargon decoding—our real-time feed, complete form coverage, and concise expert commentary turn complex filings into clear, timely intelligence.
Paychex (PAYX) insider reported a charitable gift of common stock. On 10/28/2025, the reporting person executed a Code G transaction, gifting 200 shares at $123.87 per share. Following the transaction, the filer beneficially owns 36,640,384 shares directly and 41,277 shares indirectly through the Cynthia A. Golisano Irrevocable Trust U/A dtd 6/13/2005. The filer is identified as a Director and filed individually.
Paychex (PAYX) director reported a charitable transfer of common stock. On 10/22/2025, the insider filed a Code G transaction indicating a gift of 302,050 shares to various non-profit organizations.
After the transaction, the filer reported 36,640,584 shares beneficially owned directly and 41,277 shares owned indirectly through the Cynthia A. Golisano Irrevocable Trust U/A dtd 6/13/2005.
Paychex Inc. (PAYX) reported an insider Form 4 for a senior vice president. On 10/15/2025, the officer disposed of 41 common shares at $127.52 under code F, which indicates shares were withheld to cover taxes from vested restricted stock units.
After the transaction, the officer beneficially owned 9,794 shares, held directly. The filing also lists vested and unvested stock options, including 12,164 shares at an exercise price of $120.86 (expiring 07/14/2033) and 14,291 shares at $121.63 (expiring 07/14/2034).
Paychex (PAYX) reported an insider equity award on Form 4. A director acquired 725 shares of common stock via restricted stock units on 10/15/2025 at $0, increasing beneficial ownership to 79,344 shares directly.
The filing also shows a new stock option grant for 3,061 shares at an exercise price of $127.52 on 10/15/2025, first exercisable on 10/15/2026 and expiring on 10/14/2035. Existing option holdings remain outstanding across multiple grants, with exercise prices ranging from $57.20 to $140.68 and expirations extending through 2035. The RSU award is pursuant to the Amended and Restated 2002 Stock Incentive Plan.
Paychex, Inc. (PAYX) disclosed an insider equity award. A director reported acquiring 725 shares of common stock on 10/15/2025 at $0, reflecting vested or granted shares. Following the transaction, the director beneficially owned 11,770 shares directly.
The filer also received a stock option grant for 3,061 shares at an exercise price of $127.52, exercisable 10/15/2026 and expiring 10/14/2035. The filing notes the equity award includes restricted stock units subject to vesting under the company’s Amended and Restated 2002 Stock Incentive Plan.
Paychex (PAYX) reported an insider transaction by its Sr. VP & CFO. On 10/15/2025, the officer disposed of 116 shares of common stock at $127.52 under code F, a sale to cover taxes from the vesting of restricted stock units. Following the transaction, the officer beneficially owns 19,165 shares directly and 322 shares indirectly via a 401(k). The filing also lists outstanding stock options across multiple grants with various exercise prices and expirations.
Paychex (PAYX) disclosed a director’s equity awards on Form 4. The reporting person acquired 725 shares of common stock at $0, noted as restricted stock units subject to vesting. The filing also reports a new stock option grant for 3,061 shares at $127.52 on 10/15/2025, exercisable 10/15/2026 and expiring 10/14/2035. Following the transaction, 3,951 shares of common stock were beneficially owned directly.
Paychex (PAYX) filed a Form 3 reporting initial beneficial ownership by an officer. As of the event date 10/09/2025, the reporting person, an SVP, HCM, PEO & Insurance, directly owns 6,683 shares of Common Stock.
Table II lists stock options for Common Stock as follows: 6,775 shares at $119.72 exercisable on 01/15/2025 expiring 01/14/2034; 13,192 shares at $121.63 exercisable on 07/15/2025 expiring 07/14/2034; and 11,813 shares at $140.68 exercisable on 07/15/2026 expiring 07/14/2035. The filing indicates direct ownership and was signed by an attorney-in-fact.
Paychex (PAYX) reported an insider equity award on a Form 4. A director acquired 725 shares of common stock on 10/15/2025 at $0, noted as an award of restricted stock units subject to vesting under the Amended and Restated 2002 Stock Incentive Plan. Following the transaction, the insider beneficially owned 20,504 shares, held directly.
The filing also lists a new stock option grant for 3,061 shares at an exercise price of $127.52 on 10/15/2025, exercisable 10/15/2026 and expiring 10/14/2035. Additional previously granted options with various strike prices and expirations remain outstanding.
Paychex (PAYX) — Form 4 insider activity: A company director reported equity awards dated 10/15/2025. The filing shows 725 shares of common stock acquired at $0, reflecting settlement of restricted stock units under the Amended and Restated 2002 Stock Incentive Plan. Following this, beneficial ownership stands at 67,364 shares, held directly.
The director also reported a new stock option grant for 3,061 shares at an exercise price of $127.52, granted on 10/15/2025, exercisable starting 10/15/2026 and expiring on 10/14/2035. The filing lists additional previously granted options with exercise prices and expirations on a rolling schedule.
FAQ
What is the current stock price of Paychex (PAYX)?
What is the market cap of Paychex (PAYX)?
